CITIGROUP INC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 162 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,000
-66.7%
2,064
-50.4%
0.00%
Q2 2022$3,000
-84.2%
4,160
-71.8%
0.00%
Q1 2022$19,000
-88.6%
14,777
-88.7%
0.00%
Q4 2021$166,000
-85.6%
130,359
-75.3%
0.00%
-100.0%
Q3 2021$1,150,000
-52.8%
527,434
-18.7%
0.00%0.0%
Q2 2021$2,434,000
+2.1%
648,990
-11.3%
0.00%
-50.0%
Q1 2021$2,385,000
+1196.2%
731,629
+1253.6%
0.00%
Q4 2020$184,000
+178.8%
54,052
+230.7%
0.00%
Q3 2020$66,000
-82.3%
16,345
-85.2%
0.00%
Q2 2020$373,000
+103.8%
110,465
+41.3%
0.00%
Q1 2020$183,000
-18.3%
78,164
+27.1%
0.00%
Q4 2019$224,000
-88.0%
61,475
-72.7%
0.00%
-100.0%
Q3 2019$1,870,000
+72.8%
225,471
+79.3%
0.00%0.0%
Q2 2019$1,082,000
+51.1%
125,739
+87.8%
0.00%0.0%
Q1 2019$716,000
-84.1%
66,968
-87.0%
0.00%
-75.0%
Q4 2018$4,492,000
+254.0%
513,317
+578.9%
0.00%
+300.0%
Q3 2018$1,269,000
-74.9%
75,613
-68.6%
0.00%
-75.0%
Q2 2018$5,050,000
+138.8%
240,903
+83.4%
0.00%
+100.0%
Q1 2018$2,115,000
-41.3%
131,375
-30.9%
0.00%
-33.3%
Q4 2017$3,605,000
+132.1%
190,192
+72.3%
0.00%
+200.0%
Q3 2017$1,553,000
+53.9%
110,367
-18.5%
0.00%0.0%
Q2 2017$1,009,000
+70.4%
135,421
+48.6%
0.00%0.0%
Q1 2017$592,000
+13.6%
91,134
-22.4%
0.00%
Q4 2016$521,000
+41.6%
117,417
+49.3%
0.00%
Q3 2016$368,000
+72.0%
78,642
+140.7%
0.00%
Q2 2016$214,000
-36.7%
32,666
-38.5%
0.00%
Q1 2016$338,000
+454.1%
53,104
+426.4%
0.00%
Q4 2015$61,000
-80.2%
10,089
-80.4%
0.00%
Q3 2015$308,000
+584.4%
51,398
+682.6%
0.00%
Q2 2015$45,000
+21.6%
6,568
+6.8%
0.00%
Q1 2015$37,000
-71.1%
6,149
-66.7%
0.00%
Q4 2014$128,000
+120.7%
18,491
+160.7%
0.00%
Q3 2014$58,000
-33.3%
7,093
-34.1%
0.00%
Q2 2014$87,000
-50.6%
10,762
-51.9%
0.00%
Q1 2014$176,000
-64.0%
22,392
-59.5%
0.00%
Q4 2013$489,000
+97.2%
55,309
+87.1%
0.00%
Q3 2013$248,000
-3.9%
29,560
-14.5%
0.00%
Q2 2013$258,00034,5540.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders